Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Cytokine. 2012 May;58(2):261-6. doi: 10.1016/j.cyto.2012.01.020. Epub 2012 Feb 26.
Vascular endothelial growth factor (VEGF) is involved in the development and differentiation of the vascular system. VEGF is expressed constitutively by epithelial cells from embryonic to adult kidneys and may play a key role in progression of kidney diseases. It is required for the growth and proliferation of glomerular and peritubular endothelial cells. In the kidney VEGF expression is prominently found in glomerular podocytes and in tubular epithelial cells, while VEGF receptors are mainly seen on preglomerular, glomerular, and peritubular endothelial cells.
We have investigated the role of VEGF gene polymorphisms (-2578C/A,-2549 18 bp I/D, -1154 G/A and +936 C/T) as a susceptibility marker for end stage renal disease (ESRD).
We genotyped VEGF gene polymorphism in three hundred patients and three hundred and fifty ethnically matched unrelated healthy controls free from any renal disease. These markers were studied using ARMS-PCR and PCR-RFLP methods. Patients were categorized on the basis of the histo-pathological subtypes into chronic glomerulonephritis (CGN=109), hypertensive nephrosclerosis (HTN=106) and chronic interstitial nephritis (CIN=60).
VEGF -2578C and -2549D alleles were found to be ESRD causative alleles. It was observed that there was significant differences in the frequencies of the T allele of +936C/T polymorphism among CGN, HTN and CIN respectively. VEGF -1154AA genotype and A allele were associated significantly with CGN. T-G-A-D, T-A-C-I,C-G-A-D,C-A-C-D,C-G-C-I,C-A-A-D and T-G-C-D were seven haplotypes concurred in all the ESRD patients irrespective of underlying disease. While C-G-C-D & C-G-A-I haplotypes showed risk association in CGN & CIN, C-A-C-I was observed to play predisposing role in HTN.
The results highlight the role of studied VEGF polymorphisms in end stage renal disease at large and subsequently in the three primary kidney diseases among the North Indian population.
血管内皮生长因子(VEGF)参与了血管系统的发育和分化。VEGF 在胚胎期到成年肾脏的上皮细胞中持续表达,可能在肾脏疾病的进展中发挥关键作用。它是肾小球和肾小管内皮细胞生长和增殖所必需的。在肾脏中,VEGF 表达主要见于肾小球足细胞和肾小管上皮细胞,而 VEGF 受体主要见于肾小球前、肾小球和肾小管内皮细胞。
我们研究了 VEGF 基因多态性(-2578C/A、-2549 18 bp I/D、-1154 G/A 和 +936 C/T)作为终末期肾病(ESRD)易感性标志物的作用。
我们在 300 名患者和 350 名无任何肾脏疾病的种族匹配的无关健康对照者中对 VEGF 基因多态性进行了基因分型。使用 ARMS-PCR 和 PCR-RFLP 方法研究了这些标记物。根据组织病理学亚型,患者被分为慢性肾小球肾炎(CGN=109)、高血压性肾硬化症(HTN=106)和慢性间质性肾炎(CIN=60)。
发现 VEGF-2578C 和-2549D 等位基因是 ESRD 的致病等位基因。观察到+936C/T 多态性的 T 等位基因在 CGN、HTN 和 CIN 中的频率有显著差异。VEGF-1154AA 基因型和 A 等位基因与 CGN 显著相关。T-G-A-D、T-A-C-I、C-G-A-D、C-A-C-D、C-G-C-I、C-A-A-D 和 T-G-C-D 是所有 ESRD 患者中一致存在的七个单倍型,无论潜在疾病如何。C-G-C-D 和 C-G-A-I 单倍型在 CGN 和 CIN 中显示出风险关联,而 C-A-C-I 则在 HTN 中表现出易感性。
研究结果强调了所研究的 VEGF 多态性在印度北部人群中的终末期肾病以及随后的三种原发性肾脏疾病中的作用。